KMT2A and acute promyelocytic leukemia: For example, KMT2A/MLL1‐rearrangements generally cause an aggressive disease with a poor prognosis while APML cases are considered to be of favorable outcome and respond positively to all‐trans retinoic acid (ATRA) based therapy (Pourrajab et al., 2020).